UB Paderborn / Katalog / Suche / in CDI

ESPAC-1: A European, randomised study to assess the roles of adjuvant chemotherapy and chemoradiation in resectable pancreatic cancer

European journal of cancer (1990), 2001-04, Vol.37, p.S253-S253

2001

Link zum Volltext

Verfügbarkeit prüfen

Characteristics of HLA-E Restricted T-Cell Responses and Their Role in Infectious Diseases

Journal of Immunology Research, 2016-01, Vol.2016, p.2695396-11

2016

Link zum Volltext

Verfügbarkeit prüfen

Role of HLA‐G as a Predictive Marker of Low Risk of Chronic Rejection in Lung Transplant Recipients: A Clinical Prospective Study

American journal of transplantation, 2015-02, Vol.15 (2), p.461-471

2015

Link zum Volltext

Verfügbarkeit prüfen

Report of the Wet Workshop for Quantification of Soluble HLA-G in Essen, 2004

Human Immunology, 2005-08, Vol.66 (8), p.853-863

2005

Link zum Volltext

Verfügbarkeit prüfen

Altered Immunosuppressive Properties of Lung Transplant Recipients’ Bronchial Epithelium: An Ex-Vivo Model of T-Allogenic Response

The Journal of heart and lung transplantation, 2015-04, Vol.34 (4), p.S258-S258

2015

Link zum Volltext

Verfügbarkeit prüfen

A three step supercritical process to improve the dissolution rate of Eflucimibe

European journal of pharmaceutical sciences, 2005-10, Vol.26 (2), p.184-193

2005

Link zum Volltext

Verfügbarkeit prüfen

Myocardial HLA-G Reliably Indicates a Low Risk of Acute Cellular Rejection in Heart Transplant Recipients

The Journal of heart and lung transplantation, 2008-05, Vol.27 (5), p.522-527

2008

Link zum Volltext

Verfügbarkeit prüfen

Activation of estrogen receptor transfected into a receptor-negative breast cancer cell line decreases the metastatic and invasive potential of the cells

Proceedings of the National Academy of Sciences - PNAS, 1992-12, Vol.89 (23), p.11538-11542

1992

Link zum Volltext

Verfügbarkeit prüfen

Altération des propriétés immunosuppressives de l’épithélium bronchique chez les greffés pulmonaires

Revue des maladies respiratoires, 2015-01, Vol.32, p.A177-A177

2015

Link zum Volltext

Verfügbarkeit prüfen

Rôle de HLA-G comme marqueur prédictif de faible risque de rejet chronique à long terme chez les patients greffés pulmonaires : étude clinique prospective

Revue des maladies respiratoires, 2015-01, Vol.32, p.A16-A16

2015

Link zum Volltext

Verfügbarkeit prüfen

458: A single-centre retrospective study on human leukocyte antigen-G expression in heart transplant recipients prior to, during, and following episodes of rejection

The Journal of heart and lung transplantation, 2007, Vol.26 (2), p.S225-S225

2007

Link zum Volltext

Verfügbarkeit prüfen

Association between high concentrations of Mr 52,000 cathepsin D and poor prognosis in primary human breast cancer

Cancer research (Chicago, Ill.), 1989-11, Vol.49 (21), p.6008-6014

1989

Link zum Volltext

Verfügbarkeit prüfen

Estrogen-induced lysosomal proteases secreted by breast cancer cells: A role in carcinogenesis?

Journal of cellular biochemistry, 1987-09, Vol.35 (1), p.17-29

1987

Link zum Volltext

Verfügbarkeit prüfen

Autocrine growth stimulation of the MCF 7 breast cancer cells by the estrogen-regulated 52 K protein

Endocrinology (Philadelphia), 1986-04, Vol.118 (4), p.1537-1545

1986

Link zum Volltext

Verfügbarkeit prüfen

Quantification and identification of soluble HLA-G isoforms

Tissue Antigens, 2007-04, Vol.69 (s1), p.143-149

2007

Link zum Volltext

Verfügbarkeit prüfen

Mechanisms of 4-hydroxytamoxifen anti-growth factor activity in breast cancer cells: Alterations of growth factor receptor binding sites and tyrosine kinase activity

Biochemical and biophysical research communications, 1990-12, Vol.173 (3), p.919-926

1990

Link zum Volltext

Verfügbarkeit prüfen

Anti-steroidal and anti-growth factor activities of anti-estrogens

Journal of steroid biochemistry and molecular biology, 1990-12, Vol.37 (6), p.777-781

1990

Link zum Volltext

Verfügbarkeit prüfen

Immunoenzymatic assay of Mr 52,000 cathepsin D in 182 breast cancer cytosols: low correlation with other prognostic parameters

Cancer research (Chicago, Ill.), 1988-01, Vol.48 (2), p.462-466

1988

Link zum Volltext

Verfügbarkeit prüfen

Immunoradiometric assay of pro-cathepsin D in breast cancer cytosol: Relative prognostic value versus total cathepsin D

European journal of cancer (1990), 1993, Vol.29 (9), p.1248-1251

1993

Link zum Volltext

Verfügbarkeit prüfen

Structure, function, regulation and clinical significance of the 52K pro-cathepsin D secreted by breast cancer cells

Biochimie, 1988-07, Vol.70 (7), p.943-949

1988

Link zum Volltext

Verfügbarkeit prüfen

Reaction of peripheral‐blood lymphocytes to the human chorionic gonadotropin β sub‐unit in patients with productive tumors

International journal of cancer, 1995-11, Vol.63 (5), p.633-638

1995

Link zum Volltext

Verfügbarkeit prüfen

Two-site immunoenzymometric assay for the 52-kDa cathepsin D in cytosols of breast cancer tissues

Clinical chemistry (Baltimore, Md.), 1989-01, Vol.35 (1), p.81

1989

Link zum Volltext

Verfügbarkeit prüfen

A two-site immunoenzymometric assay of 52-kDa pro-cathepsin D, and its use in human breast diseases

Clinical chemistry (Baltimore, Md.), 1989-02, Vol.35 (2), p.234

1989

Link zum Volltext

Verfügbarkeit prüfen

Tamoxifen treatment increases the concentration of 52K‐cathepsin D and its precursor in breast cancer tissue

Cancer, 1989-04, Vol.63 (7), p.1265-1270

1989

Link zum Volltext

Verfügbarkeit prüfen

Characterization and properties of two monoclonal antibodies specific for the Mr 52,000 precursor of cathepsin D in human breast cancer cells

Cancer research (Chicago, Ill.), 1988-07, Vol.48 (13), p.3709-3715

1988

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

ESPAC-1: A European, randomised study to assess the roles of adjuvant chemotherapy and chemoradiation in resectable pancreatic cancer

Characteristics of HLA-E Restricted T-Cell Responses and Their Role in Infectious Diseases

Role of HLA‐G as a Predictive Marker of Low Risk of Chronic Rejection in Lung Transplant Recipients: A Clinical Prospective Study

Report of the Wet Workshop for Quantification of Soluble HLA-G in Essen, 2004

Altered Immunosuppressive Properties of Lung Transplant Recipients’ Bronchial Epithelium: An Ex-Vivo Model of T-Allogenic Response

A three step supercritical process to improve the dissolution rate of Eflucimibe

Myocardial HLA-G Reliably Indicates a Low Risk of Acute Cellular Rejection in Heart Transplant Recipients

Activation of estrogen receptor transfected into a receptor-negative breast cancer cell line decreases the metastatic and invasive potential of the cells

Altération des propriétés immunosuppressives de l’épithélium bronchique chez les greffés pulmonaires

Rôle de HLA-G comme marqueur prédictif de faible risque de rejet chronique à long terme chez les patients greffés pulmonaires : étude clinique prospective

458: A single-centre retrospective study on human leukocyte antigen-G expression in heart transplant recipients prior to, during, and following episodes of rejection

Association between high concentrations of Mr 52,000 cathepsin D and poor prognosis in primary human breast cancer

Estrogen-induced lysosomal proteases secreted by breast cancer cells: A role in carcinogenesis?

Autocrine growth stimulation of the MCF 7 breast cancer cells by the estrogen-regulated 52 K protein

Quantification and identification of soluble HLA-G isoforms

Mechanisms of 4-hydroxytamoxifen anti-growth factor activity in breast cancer cells: Alterations of growth factor receptor binding sites and tyrosine kinase activity

Anti-steroidal and anti-growth factor activities of anti-estrogens

Immunoenzymatic assay of Mr 52,000 cathepsin D in 182 breast cancer cytosols: low correlation with other prognostic parameters

Immunoradiometric assay of pro-cathepsin D in breast cancer cytosol: Relative prognostic value versus total cathepsin D

Structure, function, regulation and clinical significance of the 52K pro-cathepsin D secreted by breast cancer cells

Reaction of peripheral‐blood lymphocytes to the human chorionic gonadotropin β sub‐unit in patients with productive tumors

Two-site immunoenzymometric assay for the 52-kDa cathepsin D in cytosols of breast cancer tissues

A two-site immunoenzymometric assay of 52-kDa pro-cathepsin D, and its use in human breast diseases

Tamoxifen treatment increases the concentration of 52K‐cathepsin D and its precursor in breast cancer tissue

Characterization and properties of two monoclonal antibodies specific for the Mr 52,000 precursor of cathepsin D in human breast cancer cells

Suchergebnisse filtern